Trial site
Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Sp. z o. o
- 16running trials
- 21closed trials
The trials here
What the 37 trials at this site are about, from their registry records.
- Conditions
- Atopic dermatitis (eczema)6 trials
- Sjögren's disease6 trials
- Ulcerative colitis6 trials
- Lupus (SLE)4 trials
- Hidradenitis suppurativa3 trials
- Type 2 diabetes3 trials
- Psoriasis2 trials
- Chronic spontaneous urticaria1 trial
- Gastroparesis1 trial
- Osteoarthritis1 trial
- Systemic sclerosis (scleroderma)1 trial
- Phase
- Phase 323 trials
- Phase 212 trials
- Phase 42 trials
- Status
- Completed20 trials
- Active, not recruiting7 trials
- Recruiting5 trials
- Not yet recruiting4 trials
- Withdrawn1 trial
- Lead sponsor
- Amgen4 trials
- Amgen Inc.3 trials
- Arrowhead Pharmaceuticals3 trials
- Novo Nordisk A/S3 trials
- Biogen2 trials
- and 19 more
Running trials
Not yet recruiting
Not yet recruiting
Recruiting
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Recruiting
Recruiting
Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease
Recruiting
A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
Active, not recruiting
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Recruiting
Active, not recruiting
Active, not recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Active, not recruiting
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Active, not recruiting
Recruiting
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)
Active, not recruiting
Enrolling by invitation
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Ulcerative colitis3 recruiting
- Lupus (SLE)2 recruiting
- Type 2 diabetes2 recruiting
- Sjögren's disease1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
Closed trials
Recruiting
Completed
Completed
Completed
Completed
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
Completed
Completed
Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia
Completed
Recruiting
Efficacy and Safety of Methotrexate Versus Placebo in Adults With Atopic Dermatitis.
Completed
Completed
Completed
Completed
Completed
BP11 Versus EU-Approved Xolair® in Patients With Chronic Spontaneous Urticaria
Completed
Completed
Completed
Completed
Completed
A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE)
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 18 Nov 2026